Cisiv launches Baseline Plus for "real world" trials

By Gareth Macdonald

- Last updated on GMT

Related tags: Clinical research

Cisiv launches Baseline Plus for "real world" trials
UK software group Cisiv has unveiled a web-based EDC platform, Baseline Plus, which is specifically tailored to meet the demands of post market trials.

Observational, or post-market studies, differ from clinical trials in that they are, by definition, non-interventional and often involve a greater number of patients and physicians over a wide area.

As a result, electronic data capture (EDC) methods developed for clinical trials are often to complex to be a practical option for “real world” situations and non-specialist operators.

Outsourcing-pharma spoke with Dominic Farmer, Cisiv CEO, about how the new Baseline Plus system can help overcome such problems and how the software fits into the growing pharmaceutical industry market for post-approval observational analysis.

Related news

Show more

Related products

show more

Using SDTM, ADaM, and SEND

Using SDTM, ADaM, and SEND

Formedix | 09-Nov-2022 | Technical / White Paper

This article gives an overview of SDTM, ADaM, SEND and ARM, and discusses how these CDISC standards fit in with the wider clinical trial process, and how...

How to design an effective CRF

How to design an effective CRF

Formedix | 10-Oct-2022 | Technical / White Paper

CRFs and eCRFs are used for gathering patient data during clinical trials. They play a crucial role in helping to assess the safety and efficacy of clinical...

Because When It's On the Line... Capability Matters.

Because When It's On the Line... Capability Matters.

Baxter BioPharma Solutions | 01-Oct-2022 | Product Brochure

Baxter’s BioPharma Solutions business supports leading pharmaceutical companies in meeting their commercialization objectives by providing scientific expertise,...

Related suppliers

Follow us

Products

View more

Webinars